BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 28601837)

  • 1. Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Ma C; Panaccione R; Fedorak RN; Parker CE; Khanna R; Levesque BG; Sandborn WJ; Feagan BG; Jairath V
    BMJ Open; 2017 Jun; 7(6):e016146. PubMed ID: 28601837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
    Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
    BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
    Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
    Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
    ; Ma C; Hanzel J; Panaccione R; Sandborn WJ; D'Haens GR; Ahuja V; Atreya R; Bernstein CN; Bossuyt P; Bressler B; Bryant RV; Cohen B; Colombel JF; Danese S; Dignass A; Dubinsky MC; Fleshner PR; Gearry RB; Hanauer SB; Hart A; Kotze PG; Kucharzik T; Lakatos PL; Leong RW; Magro F; Panés J; Peyrin-Biroulet L; Ran Z; Regueiro M; Singh S; Spinelli A; Steinhart AH; Travis SP; van der Woude CJ; Yacyshyn B; Yamamoto T; Allez M; Bemelman WA; Lightner AL; Louis E; Rubin DT; Scherl EJ; Siegel CA; Silverberg MS; Vermeire S; Parker CE; McFarlane SC; Guizzetti L; Smith MI; Vande Casteele N; Feagan BG; Jairath V
    Gastroenterology; 2022 Oct; 163(4):950-964. PubMed ID: 35788348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
    Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults.
    Duane S; Vellinga A; Murphy AW; Cormican M; Smyth A; Healy P; Moore M; Little P; Devane D
    Trials; 2019 Feb; 20(1):106. PubMed ID: 30732617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
    Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a core outcome set for fistulising perianal Crohn's disease.
    Sahnan K; Tozer PJ; Adegbola SO; Lee MJ; Heywood N; McNair AGK; Hind D; Yassin N; Lobo AJ; Brown SR; Sebastian S; Phillips RKS; Lung PFC; Faiz OD; Crook K; Blackwell S; Verjee A; Hart AL; Fearnhead NS;
    Gut; 2019 Feb; 68(2):226-238. PubMed ID: 29437911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core outcomes in periodontal trials: study protocol for core outcome set development.
    Lamont TJ; Clarkson JE; Ricketts DNJ; Heasman PA; Ramsay CR
    Trials; 2017 Sep; 18(1):436. PubMed ID: 28931440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol.
    Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R
    Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer.
    Fish R; Sanders C; Williamson PR; Renehan AG
    BMJ Open; 2017 Nov; 7(11):e018726. PubMed ID: 29170292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.
    Harman NL; Wilding J; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
    Trials; 2018 Aug; 19(1):427. PubMed ID: 30086771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a core outcome set for effectiveness studies of breech birth at term (Breech-COS)-an international multi-stakeholder Delphi study: study protocol.
    Walker S; Dasgupta T; Shennan A; Sandall J; Bunce C; Roberts P
    Trials; 2022 Apr; 23(1):249. PubMed ID: 35379305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a core outcome set for people living with dementia at home in their neighbourhoods and communities: study protocol for use in the evaluation of non-pharmacological community-based health and social care interventions.
    Harding AJE; Morbey H; Ahmed F; Opdebeeck C; Wang YY; Williamson P; Swarbrick C; Leroi I; Challis D; Davies L; Reeves D; Holland F; Hann M; Hellström I; Hydén LC; Burns A; Keady J; Reilly S
    Trials; 2018 Apr; 19(1):247. PubMed ID: 29690920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a core outcome set for studies on prevention and management of pregnancy-associated venous thromboembolism (COSPVenTE): a study protocol.
    King A; D'Souza R; Teshler L; Shehata N; Malinowski AK
    BMJ Open; 2020 Jul; 10(7):e034017. PubMed ID: 32690496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardising the reporting of outcomes in gastric cancer surgery trials: protocol for the development of a core outcome set and accompanying outcome measurement instrument set (the GASTROS study).
    Alkhaffaf B; Glenny AM; Blazeby JM; Williamson P; Bruce IA
    Trials; 2017 Aug; 18(1):370. PubMed ID: 28793921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.
    Tallouzi MO; Mathers JM; Moore DJ; Murray PI; Bucknall N; Blazeby JM; Calvert M; Denniston AK
    Trials; 2017 Dec; 18(1):576. PubMed ID: 29191216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing a core outcome set for the treatment of pregnant women with pregestational diabetes-a study protocol.
    Kgosidialwa O; Bogdanet D; Egan A; O'Shea PM; Biesty L; Devane D; Dunne F;
    Trials; 2020 Dec; 21(1):1017. PubMed ID: 33308263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey.
    MacLennan S; Bekema HJ; Williamson PR; Campbell MK; Stewart F; MacLennan SJ; N'Dow JM; Lam TB
    Trials; 2015 Mar; 16():76. PubMed ID: 25887437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Henley JK; Ashchyan HJ; Kurta AO; Patel PM; Sheikh UA; Franklin MJ; Hanna CC; Chen BR; Chiren SG; Schmitt J; Deckert S; Furlan KC; Poon E; Maher IA; Cartee TV; Sobanko JF; Alam M
    Trials; 2017 Aug; 18(1):359. PubMed ID: 28764734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.